Amatsigroup - a global CDMO (contract development and manufacturing organization) providing services in preclinical and clinical phases of drug development.
With over 250 highly qualified employees and a diversified portfolio of 300 international clients, pharmaceutical laboratories and biotechnology companies, Amatsigroup is the French leader in services for pharmaceutical product development in human and animal health.
Amatsigroup offers a wide range of international services in its four strategic business areas: bioservices (in life studies and bioanalysis); pharmaceutical analysis solutions; formulation development and manufacturing; and packaging & logistics of clinical batches, under GLP and GMP environment (European & US accreditations).
Our services for clinical trial supply:
Amatsigroup has five operational sites in Europe (Amatsi, AmatsiAvepharm, AmatsiAvogadro, AmatsiDBi, AmatsiSEPS) and one site in the US (Amatsigroup Inc).
Contact: Marie-Christine Bodinier - EVP global business development
Tel: +33 (0)5 34 01 21 30